What is AOD-9604?
AOD-9604 is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH). Engineered to mimic hGH’s fat-metabolism signaling without the growth-promoting effects, AOD-9604 has been investigated for its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation). Early studies suggest it operates via peripheral metabolic pathways rather than androgenic or anabolic mechanisms, making it an intriguing research candidate for body-composition and metabolic investigations.
AOD-9604 Benefits & Research:
- hGH Fragment Mechanism: Utilizes the 176–191 region of hGH that targets fat metabolism signaling without activating growth-related pathways.
- Promotes Lipolysis: Studied for increasing breakdown of stored triglycerides in adipocytes and mobilizing fatty acids.
- Inhibits Lipogenesis: Research indicates potential suppression of new fat creation, supporting a more favorable energy balance.
- Non-Anabolic / Non-Androgenic: Investigated for metabolic effects independent of muscle-growth or androgen pathways.
- Does Not Elevate IGF-1 (In Studies): Designed to avoid the mitogenic effects associated with full-length hGH signaling.
- Non-Stimulant Profile: Explored as a fat-loss research agent without central-nervous-system stimulation.
- Compatible With Lifestyle Interventions: Often studied alongside diet and activity protocols to evaluate combined effects on body composition.
- Focused Metabolic Research: Positioned as a targeted tool for investigating adipose-tissue dynamics and metabolic health markers.
For laboratory research use only. Not for human consumption, medical, or veterinary use.
